FR3713M - Pyrimido [5,4-d] pyrimidines basiquement substituées. - Google Patents

Pyrimido [5,4-d] pyrimidines basiquement substituées.

Info

Publication number
FR3713M
FR3713M FR977447A FR977447A FR3713M FR 3713 M FR3713 M FR 3713M FR 977447 A FR977447 A FR 977447A FR 977447 A FR977447 A FR 977447A FR 3713 M FR3713 M FR 3713M
Authority
FR
France
Prior art keywords
pyrimidines
basically substituted
substituted pyrimido
pyrimido
basically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR977447A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR966678A external-priority patent/FR1543161A/fr
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Priority to FR977447A priority Critical patent/FR3713M/fr
Application granted granted Critical
Publication of FR3713M publication Critical patent/FR3713M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR977447A 1963-03-09 1964-06-08 Pyrimido [5,4-d] pyrimidines basiquement substituées. Expired FR3713M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR977447A FR3713M (fr) 1963-03-09 1964-06-08 Pyrimido [5,4-d] pyrimidines basiquement substituées.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DET0023605 1963-03-09
FR966678A FR1543161A (fr) 1963-03-09 1964-03-09 Procédé de fabrication de pyrimido [5, 4-d]-pyrimidines basiquement substituées
FR977447A FR3713M (fr) 1963-03-09 1964-06-08 Pyrimido [5,4-d] pyrimidines basiquement substituées.

Publications (1)

Publication Number Publication Date
FR3713M true FR3713M (fr) 1965-11-29

Family

ID=7551073

Family Applications (1)

Application Number Title Priority Date Filing Date
FR977447A Expired FR3713M (fr) 1963-03-09 1964-06-08 Pyrimido [5,4-d] pyrimidines basiquement substituées.

Country Status (5)

Country Link
CH (1) CH438344A (enExample)
DE (1) DE1470341C3 (enExample)
FR (1) FR3713M (enExample)
GB (1) GB1051218A (enExample)
IT (1) IT7950418A0 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12037346B2 (en) 2021-04-13 2024-07-16 Nuvalent, Inc. Amino-substituted heteroaryls for treating cancers with EGFR mutations

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2004201A1 (de) * 1970-01-30 1971-08-05 Thomae Gmbh Dr K Neue 2,6-Bis(dialkanolamino)-pyrimido-[5,4-d]pyrimidine und Verfahren zu ihrer Herstellung
DE3049207A1 (de) * 1980-12-27 1982-07-29 Dr. Karl Thomae Gmbh, 7950 Biberach Neue trisubstituierte pyrimido (5,4-d) pyrimidine, ihre herstellung und ihre verwendung als arzneimittel
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
KR20060007034A (ko) 2003-04-24 2006-01-23 베링거 인겔하임 인터내셔날 게엠베하 혈전색전증 질환 및 트롬빈의 과형성 및/또는 트롬빈수용체의 상승된 발현에 의해 유발된 질환 및 장애를치료하고 예방하기 위한, 디피리다몰 또는 모피다몰의 용도
MX2009013293A (es) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA3100941C (en) 2011-03-01 2024-03-05 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
KR20160042039A (ko) 2013-08-09 2016-04-18 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12037346B2 (en) 2021-04-13 2024-07-16 Nuvalent, Inc. Amino-substituted heteroaryls for treating cancers with EGFR mutations

Also Published As

Publication number Publication date
DE1470341A1 (de) 1969-07-03
DE1470341C3 (de) 1974-07-04
CH438344A (de) 1967-06-30
DE1470341B2 (de) 1973-12-06
IT7950418A0 (it) 1979-10-01
GB1051218A (enExample)

Similar Documents

Publication Publication Date Title
DK121158B (da) Smæklås.
FI51674C (fi) Hydropneumaattinen järjestelmä.
CA931568A (en) Pyrazolo(3,4-d)pyrimidines
FR3773M (fr) Nouvelles 5h-dihydrothiopyrano-[4,3-d]-pyrimidines.
FR3648M (fr) Dihydrothiéno[3,2-d]pyrimidines.
NL141512B (nl) Werkwijze ter bereiding van 4-hydroxypyrazool(3,4-d)-pyrimidine.
FR1425M (fr) Nouvelle pyrazolo-[3,4-d]-pyrimidine.
FR3873M (fr) 5,6-dihydro-6-oxo-11h-pyrido [2,3-b] [1,4] benzodiazépines substituées en position 5.
BE762328A (fr) Nouvelles 2,6-dimorpholino-8-alcanolamino pyrimido(5,4-d) pyrimidines
FR2461M (fr) Pyrimido[4,5-d]pyrimidines substituées.
CA754565A (en) 4-substituted-1-alkyl-6-(2-furyl)-1h-pyrazolo(3,4-d)pyrimidines
CA733107A (en) Substituted pyrimido (4,5-d) pyrimidines
FR3761M (fr) Nouvelles dihydrothiéno-[3,4-d]-pyrimidines.
BE670883A (fr) Ptéridines.
AU414826B2 (en) BILOGICALLY ACTIVE PYRAZOLO PYRIMIDINES. osc
AU285583B2 (en) 2,4-DLAMINOPYRIDO 2,3-d PYRIMIDINES
AU595866A (en) BILOGICALLY ACTIVE PYRAZOLO PYRIMIDINES. osc
IE31679L (en) Substituted pteridines.
ES125510Y (es) Semiremolque de utilidad multiple.
DK125248B (da) Analogifremgangsmåde til fremstilling af 2,6-dimorpholino-8-alkanolamino-pyrimido[5,4-d]pyrimidiner.
CA677086A (en) 2-substituted pyrimidines
CA791720A (en) Pyrimido-(5,4-d)-pyrimidines
CA656747A (en) Triazolo (d) pyrimidine derivatives
YU31296B (en) Postupak za oplemenjivanje briketa uglja i vezivnog materijala, iz biljke lespedeza capitata, u suvom stanju ili u obliku vodenog rastvora
FR3312M (fr) Acéthylaspartate de caféine.